Kemwell Biopharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Kemwell Biopharma Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10805
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kemwell Biopharma Pvt Ltd (Kemwell) formerly Kemwell Pvt Ltd a subsidiary of Recipharm AB is a healthcare solutions provider that offers product development and manufacturing solutions. The organization provides contract pharmaceutical development and manufacturing organization and concentrates on the development of drugs. It offers services such as drug prototype development, pre-formulation,formulation development, analytical method development and validation, process optimization, stability testing and storage, and scale-up. Kemwell provides comparator product modification for blinding studies, lab and pilot scale manufacture, clinical packaging and labeling, registration batch manufacture, and technology transfer. The organization offers products in dosage forms of oral, semi-solids, liquids, parenteral and first-in-human formulations. It operates in India, Sweden and the US. Kemwell is headquartered in Bangalore, Karnataka, India.

Kemwell Biopharma Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Acquisition 10
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd – Key Competitors 14
Kemwell Biopharma Pvt Ltd – Key Employees 15
Kemwell Biopharma Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Other Significant Developments 17
May 17, 2017: Kemwell Biopharma Supplies Biologics Drug Substance for Phase 1 Clinical Trials for US IND Filing 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Kemwell Biopharma Enters into Co-Development Agreement for Monoclonal Antibody Therapeutics 9
Recipharm Acquires Kemwell Biopharma for USD120 Million 10
Recipharm Acquires Kemwell and Cirrus Pharma from Kemwell Biopharma 11
Kemwell Biopharma Acquires Cirrus Pharma 13
Kemwell Biopharma Pvt Ltd, Key Competitors 14
Kemwell Biopharma Pvt Ltd, Key Employees 15

List of Figures
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Kemwell Biopharma Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Kemwell Biopharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HealthSouth Corporation (HLS)(製薬・医療分野):企業M&A動向
    Summary HealthSouth Corporation (HealthSouth) is a healthcare service provider. The company owns and operates inpatient rehabilitation and hospitals to provides healthcare and medical care services. Its services consist of treatment to medical conditions such as brain injury, cardiac care, diabetes, …
  • EnBW Energie Baden-Wurttemberg AG (EBK)-石油・ガス分野:企業M&A・提携分析
    Summary EnBW Energie Baden-Wuerttemberg AG (EnBW) is an integrated energy holding company that generates, procures, transmits and supplies electricity; and produces, transports and supplies gas through its subsidiaries. Its generation portfolio includes nuclear, coal, oil, gas, wind, and pumped stor …
  • Unilife Corporation (UNIS) – Product Pipeline Analysis, 2016 Update
    Summary Unilife Corporation (Unilife) is a developer and commercial supplier of injectable drug delivery systems with focus on wearable injector products. It develops, manufactures and distributes safety engineered syringes for medical device and pharmaceutical industries. The company's product port …
  • Etihad Airways P.J.S.C.:企業のM&A・提携・投資分析
    Etihad Airways P.J.S.C. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Etihad Airways P.J.S.C. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Oglethorpe Power Corporation:企業のM&A・提携動向(発電分野)
    Summary Oglethorpe Power Corporation (Oglethorpe) is a member-owned non-profit electric utility that provides wholesale electric power to 38 retail electric distribution cooperative members. The cooperative operates through a diverse portfolio of owned and leased power supply resources utilizing nat …
  • Aleva Neurotherapeutics SA:企業のM&A・提携動向(医療機器分野)
    Summary Aleva Neurotherapeutics SA (Aleva) is a medical device company that provides neuro-stimulation solutions. The company offers products which include deep brain stimulation systems and deep brain stimulation diagnostic systems. Its deep brain stimulation systems provide directional stimulation …
  • CHC Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary CHC Group Ltd (CHC) is a provider of helicopter services. The company offers various services including offshore transportation; search and rescue in challenging and hostile environments, from remote, perilous, and extreme terrains to offshore rescues; maintenance, repair, and overhaul; and …
  • AMETEK Inc (AME):医療機器:M&Aディール及び事業提携情報
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • Vietnam Petroleum transport Joint Stock Company (VIP):企業概要、財務及び戦略的SWOT分析
    Summary Vietnam Petroleum Transport Joint Stock Company (VIPCO) is a petroleum products transportation company. The company transports petroleum products through tankers. It offers petroleum transport, real estate, providing crew, sea port, training, among others. VIPCO transports products, includin …
  • Intermountain Rural Electric Association:企業の戦略的SWOT分析
    Intermountain Rural Electric Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Pluristem Therapeutics Inc (PSTI):企業財務及び戦略的SWOT分析
    Summary Pluristem Therapeutics Inc (Pluristem) is a biotechnology company that develops cell therapies. The company’s product pipeline includes PLX-PAD for multiple therapeutic indications and PLX -R18 for hematological indications and acute radiation exposure for the treatment of a broad spectrum o …
  • Durata Therapeutics, Inc. (DRTX)(製薬・医療分野):企業M&A動向
    Summary Durata Therapeutics, Inc. (Durata) is a pharmaceutical company. It undertakes the development and commercialization of therapeutics for the treatment of infectious disease and acute illnesses. The company holds expertise in acquiring, developing and commercializing clinical stage pharmaceuti …
  • Datacraft Asia Pte., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Datacraft Asia Pte., Ltd. Merge …
  • Guangzhou R&F Properties Co Ltd:企業の戦略・SWOT・財務情報
    Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BioForce Nanosciences Holdings, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BioForce Nanosciences Holdings, …
  • JBS S.A.:戦略・SWOT・企業財務分析
    JBS S.A. - Strategy, SWOT and Corporate Finance Report Summary JBS S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Osaka Securities Exchange Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Osaka Securities Exchange Co., …
  • Ceylinco Insurance PLC:企業の戦略・SWOT・財務分析
    SummaryCeylinco Insurance PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Litha Healthcare Group Limited (LHG):(医療機器分野)企業M&A及び提携動向
    Summary Litha Healthcare Group Limited (Litha Healthcare) is a healthcare services, products and solutions provider. It provides its services to public and private hospitals, pharmacies, general and allied practitioners, as well as government healthcare programmes. The group’s business is divided in …
  • Perficient, Inc.:企業のM&A・提携・投資分析
    Perficient, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Perficient, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆